Corrigendum to ''Spinosad blocks CHRNA5 mediated EGFR signaling pathway activation to inhibit lung adenocarcinoma proliferation'' [Biomed. Pharma. 177 (2024) 117105]

Affiliations

• ¹ College of Life Science, Sichuan Normal University, Chengdu, Sichuan 610101, China; Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
• ² Zhuji People's Hospital Affiliated to Wenzhou Medical University, Zhuji, Zhejiang 311899, China.
• ³ Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China.
• ⁴ Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China; Hangzhou Medical College, Hangzhou, Zhejiang 310059, China.
• ⁵ College of Life Science, Sichuan Normal University, Chengdu, Sichuan 610101, China. Electronic address: [email protected].
• ⁶ Cancer Institute of Integrative Chinese and Western Medicine, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, China; Hangzhou Medical College, Hangzhou, Zhejiang 310059, China. Electronic address: [email protected].